title: [Medical treatment for correction of hemodynamic, rheological and metabolic changes in young patients with glaucoma associated with myopia].
abstract: The goal is to estimate the use and efficacy of differentiated approach to complex treatment of glaucomatous optic neuropathy in patients with primary open-angle glaucoma (POAG) associated with myopia. 71 patients aged 18-32 years old with POAG and high myopia and surgically or drug-induced normalized intraocular pressure were examined. The 1st group included 39 patients with ischemic form of POAG, 2nd group--32 patients with discirculatory form of POAG and the 3rd control group--10 patients of similar age with stable high myopia. Patients of the 1st group took glycine, ceraxon, actovegin and lymphotropic 1.0% nicotinic acid solution. Vasobral and cortexin were administered in the 2nd group. Medication provides correction of hemodynamic, theological and metabolic changes, that influence the clinical course of glaucoma associated with myopia.
authors.forename: G V
authors.initials: GV
authors.lastname: Shkrebets
mesh_terms: D000293:Adolescent; D000328:Adult; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000009:adverse effects; D003941:Diagnostic Techniques, Ophthalmological; D004359:Drug Therapy, Combination; D005123:Eye / Q000098:blood supply; D005260:Female; D005902:Glaucoma, Open-Angle / Q000150:complications / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects*; D008297:Male; D009216:Myopia / Q000150:complications / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy*; D018696:Neuroprotective Agents / Q000008:administration & dosage / Q000009:adverse effects; D013508:Ophthalmologic Surgical Procedures / Q000379:methods*; D009901:Optic Nerve Diseases / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D012039:Regional Blood Flow / Q000187:drug effects*; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents; D018696:Neuroprotective Agents